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SIGNALING PATHWAYS IN CHONDROCYTE PATHOLOGY
F. Beier, C.G. Appleton, S. Ohora, A. Ratneswaran, V. Pitelka,
M.A. Pest, S.E. Usmani. Univ. of Western Ontario, London, ON, Canada
Purpose: Cartilage degeneration is one of the hallmarks of osteoar-
thritis (OA). Numerous studies have shown that changes in the behavior
of cartilage cells (chondrocytes) themselves contribute to cartilage
degeneration. Many signals including growth factors, cytokines and
matrix fragments act on chondrocytes and control a plethora of intra-
cellular signaling pathways. Our studies have identiﬁed the growth
factor TGFalpha as a promoter of cartilage degeneration. The purpose of
this study was to identify downstream signaling pathways and targets
mediating TGFalpha effects on chondrocytes.
Methods:Mouse and rat models of OAwere analyzed using histological
and molecular approaches. These in vivo studies were complemented
by cell and organ culture experiments using rat primary chondrocytes
or cartilage explants cultured in the presence or absence of TGFalpha
and modulators of downstream pathways. Outcome measures include
gene and protein expression measured by qPCR and Western blotting.
Results:We identiﬁed the ERK1/2, RhoA/ROCK, p38 and PI3 K signaling
pathways as main mediators of TGFalpha actions on chondrocytes.
Amongst other responses, these pathways control the expression of the
chemokine CCL2 and the endothelin A receptor, both of which
contribute to the catabolic activities of TGFalpha.
Conclusions: TGFalpha induces a complex array of downstream
signaling events leading to increased CCL2 and endothelin signaling
that further promotes cartilage breakdown in OA.
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CLINICAL RELEVANCE OF IMAGING IN OSTEOARTHRITIS – THE
RADIOLOGIST'S PERSPECTIVE
M.D. Crema. Boston Univ., Boston, MA
Imaging methods, especially magnetic resonance imaging (MRI), have
been providing useful insights regarding the relationship between
pathology in different structures of the joint and symptoms, as well as
pathogenesis and progression of osteoarthritis. A variety of imaging
methods is available and may be applied to assess qualitatively and
quantitatively structures around the joint such as articular cartilage,
subchondral bone, synovium, ligaments, and peri-articular soft-tissues.
However, the choice of imaging methods and the use of adequate soft-
ware and hardware are of utmost importance to properly evaluate each
joint structure. MRI is the reference standard imaging method to assess
different joint structures regarding osteoarthritis given its ability to
manipulate contrast between different tissues, multiplanar capability,
and high spatial resolution. Several reliable semiquantitative scoring
systems have been applied to large observational studies and interven-
tional clinical trials. Quantitative assessment is a powerful tool when
changes occur homogeneously throughout large areas or structures in
the joint. Compositional imaging has increased our ability to detect and
monitor early degeneration before morphologic changes are present,
which may help to prevent permanent structural changes commonly
seen in OA. Optimization of the new available three-dimensional fast
spin-echo sequences is of interest in osteoarthritis research since it may1063-4584/$ – see front matter.signiﬁcantly reduce the time of acquisition while maintaining high
resolution and quality imagingwith spin-echo contrast. Ultrasoundmay
play a role in monitoring inﬂammation affecting articular and peri-
articular soft-tissues in osteoarthritis such as the synovium. Nuclear
medicine and dynamic contrast-enhanced (DCE) MRI are potential tools
to assess inﬂammation. Imaging became a major and relevant instru-
ment for the understanding of genesis and progression of osteoarthritis,
as well as for monitoring different therapies.
I-3
IMPLICATIONS OF CLINICAL BIOMECHANICS RESEARCH ON
REHABILITATION FOR OA
T. Birmingham. Univ. of Western Ontario, London, ON, Canada
Agrowing focus of rehabilitation forOA is based on clinical biomechanics
research, deﬁned as the application of biomechanics to the treatment of
patients. Clinical biomechanics can provide assistance with the identi-
ﬁcation of risk factors for disease and with the evaluation of interven-
tions. Motion analysis laboratories capable of measuring three-
dimensional kinematics and kinetics, often in combination with elec-
tromyography, have become amainstay for evaluating a joint's dynamic,
biomechanical environment. The vast majority of this research is
directed towards the knee during walking, both because of the high
prevalence of knee OA and because of the suitability of motion analysis
laboratories for describing tibiofemoral joint loading. The external knee
adduction moment receives particular attention in OA research and has
important strengths and limitations regarding its relationship with
internal knee joint loads and with the progression of disease. Although
rehabilitation often targets biomechanics, it ultimately aims to improve
pain, function and quality of life. Accordingly, the use of biomechanical
measures as outcomes in clinical trials of rehabilitative interventions is
perhaps their most promising, yet often disputed, application. For
example, rehabilitative interventions intended to alter knee joint loads,
and potentially disease progression, include: various functional
strengthening and gait re-trainingmethods focused on altering dynamic
alignment; weight-loss; knee braces; footwear and orthotics; and gait
aids. Abundant research suggests that many of these interventions can
indeeddecrease the knee adductionmoment, although effect sizes range
considerably, and what constitutes a clinically important change is
unclear. When evaluated with randomized clinical trials using patient-
important outcomes, the effectiveness of these interventions is much
more variable. Exploring strategies that improve a joint's biomechanics
is essential. Greater application to rehabilitation may rely on increased
efforts to describe the clinical measurement properties of proposed
biomechanical outcomemeasures, and on randomized clinical trials that
evaluate changes in such measures in combination with other potential
surrogate and patient-important outcomes.
I-4
INNOVATION IN MOLECULAR IMAGING WITH MASS SPECTROMETRY:
RUNNING TOWARDS HIGH RESOLUTION
R.M. Heeren. FOM-AMOLF, Amsterdam, Netherlands
The study of molecular signaling processes related to osteoarthritis
requires not only the detection and analysis of the molecules involved
but also the evaluation of their spatial organization. This allows the
